California 🇺🇸🧫👩🏻🔬 #synbiobeta2024 #girlsjustwannadoscience 💛 @p.happi.hq
Insempra Secures $20 Million Investment to Pave the Way for Next-Gen #BioBased Ingredients: Read more at the link in our bio. Image: Jens Klein, founder and CEO of Insempra, speaking at #SynBioBeta2024.
In today's episode of Grow Everything, Karl and Erum bring you the latest innovations highlighted at SynBioBeta 2024, focusing on the exciting intersection of AI and biotechnology. Hear about the groundbreaking work from the ARC Institute in whole genome sequencing and the newest advancements in AI-driven protein synthesis that are set to change the landscape of synthetic biology. They also touch on the potential of bioluminescent plants and the latest progress in space biomanufacturing. With expert insights and firsthand accounts from the conference, this episode offers a glimpse into the future of biotech and AI, sparking curiosity and excitement for what's to come. Listen to the new episode on your favorite streaming service! #GrowEverythingPodcast #SynbioBeta2024 #BiotechRevolution #AIinBiotech #GenomicsInnovation #ProteinSynthesis #FutureOfBiotech #SyntheticBiology #SpaceBiomanufacturing
In today's episode of Grow Everything, Karl and Erum bring you the latest innovations highlighted at SynBioBeta 2024, focusing on the exciting intersection of AI and biotechnology. Hear about the groundbreaking work from the ARC Institute in whole genome sequencing and the newest advancements in AI-driven protein synthesis that are set to change the landscape of synthetic biology. They also touch on the potential of bioluminescent plants and the latest progress in space biomanufacturing. With expert insights and firsthand accounts from the conference, this episode offers a glimpse into the future of biotech and AI, sparking curiosity and excitement for what's to come. Listen to the new episode on your favorite streaming service! #GrowEverythingPodcast #SynbioBeta2024 #BiotechRevolution #AIinBiotech #GenomicsInnovation #ProteinSynthesis #FutureOfBiotech #SyntheticBiology #SpaceBiomanufacturing
some highlights from #synbiobeta2024 : valleys of death, minimal cells, synthetic chromosomes, ai fossils, lab to table, designed amino acids
Had a blast at #SynBioBeta2024 with John Cumbers and Martine Rothblath where I received the Life Achievement Award. (Check out our mini mes!) Thanks to all who showed up to hear our discussion!
Nobel Laureate Thomas Südhof (@stanford) and founder Mark Kotter (@bit.bio) chat with @SynBioBeta ‘s very own @johncumbers about a cell’s identity. An engaging conversation to close out the day about the next frontier of #synbio for human health: programming human cells. This new paradigm, combined with our ability to read, write, and execute genetic code, opens unprecedented opportunities for programming human cells and improving human health. #synbiobeta2024 #synbiobeta
San Jose Mayor Matt Mahan (@MattMahanSJ) addressed #synbiobeta2024 as we close out our final day! He welcomes investors, incubators, lab and companies to San Jose, the heart of Silicon Valley, to become the platform of your success! #synbiobeta2024 #synbiobeta
Timothy Smith (@bitbio), Chris Hempel (SparkPR), Tilmann Buerckstuemmer (Myllia Biotechnology), and Martin Jacko (Aperture Therapeutics) discuss new techniques to improve CRISPR screening outcomes and the trade-offs in using different cell models for CRISPR screening. #synbiobeta2024 #synbiobeta
Gors in the Wild: Martin Borch Jensen just wrapped his talk on the main stage at #synbiobeta2024 where he enlightened like minds on how the Gordian platform tests hundreds of gene therapies simultaneously in a single animal. Also, we like that his outfit matches the decor! #InVivoVeritas #VivaInVivo #conferencestyle
UK delegation 🇬🇧 at #SynBioBeta2024:
Exciting panel discussion with Nik Evitt (@SwitchBioworks), Andrea Hodgson (Schmidt Sciences), Yonatan Chemla @yonchem (@MIT), Hannah Boardman (DSIT) and John Marken (@caltech). They discuss environmental challenges, from securing our food supply against a changing climate to restoring polluted ecosystems through the use of genetically engineered organisms (GEMs)! #synbiobeta2024
Sign up to learn about the latest industry insights and upcoming events: https://www.synbiobeta.com/sign-up-for-our-digest #synbiobeta2024
So many strong women here at this luncheon at #synbiobeta2024. Here to inspire and uplift one another by sharing our stories whether it's founder-led or building community. #womeninstem #womenleaders #synbio #syntheticbiology #synbiobeta
Shannon Hall from @powbio interviews Michael Tai from Boston Bioprocess, @AliWing from @ooblifoods, @JohnJNicols from Organicols, and Richard Kenny from Hawkwood Biotech Partners about the tradeoffs to consider when trying to get VC funding. Currently capital is in a storming period, what approaches should companies take in order to achieve success? #venturecapital #VCfunding #synbio #syntheticbiology #synbiobeta #synbiobeta2024
Discovering new therapies for complex age-related disease: @GordianBio’s co-founder and CSO Martin Borch Jensen (@MartinBJensen) shares how they are moving successful therapeutics toward clinical trials within months. #synbiobeta2024 #synbiobeta
Taci Pereira from Systemic Bio talks about 3D bioprinted tissues. The company has developed ways to develop vasculatures that can fuse with a variety of therapies. This platform leverages #AI to better understand disease and healthy models. #ai #therapies #synbio #syntheticbiology #synbiobeta #synbiobeta2024
Robert Speight (@CSIRO) and Michele Stansfield @MicheleStansfi4 (@cauldronferm) share the pillars of Australia’s SynBio ecosystem: research activity (including quantum biotechnology, FIRST of its kind in the world!), national, state and regional policy, and startups! They talk about achieving the first industrial scale for producing GMOs, which signals the support the Australian government is willing to provide in enabling industries intending to reduce carbon production. #synbiobeta2024
Mary Lou Jepson (@mljmljmlj) talks about using open-source platform to help reduce cost and shorten timelines where companies can deliver therapies within 3 years and $19M rather than the average of 13 years and $522M. Wow! #synbiobeta #synbiobeta2024
Rory Kelleher from @nvidia continues our discussion on #AI and #biology as he chats with @AnnaMarieWagner (@Ginkgo) about the coming of digital biology. At the healthcare sector, NVIDIA BioNeMo is working to bring generative AI to the world of drug discovery! #synbiobeta2024 #synbiobeta #synbio
Anna Marie Wagner (@AnnaMarieWagner) from @Ginkgo speaks with Rory Kelleher from @nvidia about digitizing biology using AI models and deep learning enabled by computing power that has recently scaled at orders of magnitude. #AI #synbiobeta2024
Data quality can’t be compromised and time cannot be bought. Jaclyn Greimann of Beckman Coulter Life Sciences (@BCILifeSciences) talks about automating strain construction to minimize tip usage, reducing waste. #synbiobeta2024 #synbiobeta #synbio #syntheticbiology #automation
Jaclyn Greimann from Beckman Coulter Life Sciences (@BCILifeSciences) talks about balancing priorities and mentions data quality cannot be compromised. However, how can you balance this alongside sustainability initiatives? This is where innovation comes to play! #sustainability #synbio #syntheticbiology #synbiobeta #synbiobeta2024
Erin Kim interviews @SuveenSahib, Steve Weiss, and Rocky Graziose about creating partnerships that could potentially lead into acquisitions and creating shareholder value. Build value and everything else will fall into place! #acquisitions #partnerships #exitstrategy #synbio #syntheticbiology #synbiobeta #synbiobeta2024
Patrick Hsu (@pdhsu) and his team at Arc Institute (@arcinstitute) are using #AI to compose novel #DNA sequences. Their model EVO is helping us 'speak the language of evolution' through whole genome training. #synbiobeta2024 #AI #machinelearning #evolution #biotechnology #bioengineering
Day 3 is last but not least. Ready for the final round of invigorating talks! #synbio #syntheticbiology #synbiobeta #synbiobeta2024
🚨 Attention SynBioBeta Enthusiasts! 🧬🔬 We have an EXCLUSIVE offer you won't want to miss! 🌟 Secure your spot at SynBioBeta 2025 and save BIG! 💰 🎟️ Purchase a full-price pass before this Friday, May 17th, and receive 2-for-1: Bring a friend or colleague for FREE! 👥 🕰️ Time is running out! Don't miss your chance to get the LOWEST price for SynBioBeta 2025 tickets. 🏃♂️💨 Register now at the link in our bio. #SynBioBeta2025 #SyntheticBiology #BiotechDeals #InnovationAwaits #SynBioBeta2024
Highlights from #SynBioBeta2024:
Having a blast at #SynBioBeta2024!
Christopher Hart from @creyonbio chats with @jason_pontin from @DCVC about Creyon's antisense oligonucleotide medicine that blocks an mRNA that codes a gene of interest, which went from concept to dosing within 13 months. #synbio #syntheticbiology #synbiobeta #synbiobeta2024 #oligotherapeutics #therapies #raredisease
Daan Luining from Meatable @itsmeatable talks about scaling and finding efficiencies for cultivated meat. It's all about the fat for tasty product! #synbio #syntheticbiology #synbiobeta #synbiobeta2024
Arvind Gupta @arvndgpta from @MayfieldFund says finding circular ways of using waste into better products will be revolutionary within the next 5 to 10 years. #syntheticbiology to support a more sustainable future. #synbio #sustainability #synbiobeta #synbiobeta2024
Bruce Li from TJX Bioengineering talks about the Hidden Costs of Outsourcing Bioprocess Development. #bioprocess #synbio #syntheticbiology #synbiobeta #synbiobeta2024
Drew Berry presents his beautiful and vibrant biomedical animation of various chemicals, from cellulose to ATP synthase, powerfully using animation for scientific education and integration in film. Behind his colorful work is hard work, collaboration, and meticulous experimentation. #synbiobeta2024 #syntheticbiology #animation
How can DNA synthesis companies screen AI-generated sequences? Sarah Carter (Science Policy Consulting LLC), Jacob Beal (RTX BBN Technologies), Nicole Wheeler (University of Birmingham), and Kevin Flyangolts (Aclid) discuss screening standards and biosecurity in the DNA synthesis industry. #syntheticbiology #ai #biosecurity #synbiobeta2024
Hello automation, bye-bye manual labor! This afternoon, a Main Stage panel discussed how circuit chips and AI handle complexities with lab automation. Altos Labs’ Tijana Radivojevic even compared the journey of transportation — from cars without seatbelts to self-driving cars — to what’s happening with self-driving labs now! #ai #self-driving-labs #automation #synbiobeta2024
Ten years ago, many companies weren't using lab automation, now it's the norm. Data forward business models is key to creating new #synbio companies. AI + automation accelerates growth in #syntheticbiology. #ai #synbiobeta #synbiobeta2024
Can organs be kept alive outside the body? Jane Metcalfe from proto.life, Zvonimir Vrselja from Bexorg, and Joydeep Bhadury from Stanford talk about keeping brains, hearts, kidneys, and other organs alive outside the body to be used as drug testing platforms and as life-saving transplants. #synbiobeta2024
How to achieve critical mass in #syntheticbiology adoption? Find economies of scale, bear in mind that B2B is what moves the needle, have a story for your product and mission. #bioeconomy #synbio #synbiobeta #synbiobeta2024
🌿🔬 Discover the future of cellular agriculture with Frank Jaksch from Ayana Bio, Chris Meaney from Green Bioactives, Bob Weinstein from Robertet, Inc, Jason Kakoyiannis from Ferment, and Bonnie Brayton from Fulcrum Global Capital at #synbiobeta2024! 🌱 Join us for insights into plant cell culture's emerging role. #synbio #syntheticbiology #cellularagriculture
Climate change has disrupted supply chains worldwide, generating greater attention from businesses and investors towards corporate responsibility. Our amazing panelists engage in a valuable discussion on the interconnectedness between profits and planet wellbeing. #synbiobeta2024 #syntheticbiology #climatechange
David Brooke of Dyno Therapeutics (@Dyno_Tx) reveals how we don’t need to rely on evolution to help sequence diversity. They are developing their own ML technology to move beyond the natural sequences. #synbiobeta2024 #synbiobeta #synbio #syntheticbiology
Here at #synbiobeta2024 we're all about celebrating bioproduction. Come join us and enjoy one of the world's oldest bioproducts (a.k.a beer and wine) #bioeconomy #biotechnology #fermentation
CEO James Petrie shares how @NourishHQ is making alternative proteins cook, smell and taste as delicious as the real thing, but animal free. #synbiobeta2024 #synbiobeta #synbio #syntheticbiology
Matterworks CEO Jack (J.M.) Geremia reveals how they have created the first large spectral models (LSM’s) tackling molecular omics! #synbiobeta2024 #synbiobeta #synbio #syntheticbiology
Kristy Hawkins brings to light how Antheia (@antheiabio) is scaling highly engineered strains to produce complex pharmaceuticals. #synbiobeta2024 #synbiobeta #synbio #syntheticbiology
Alex Colville of age1 and Vinod Khosla of Khosla Ventures at #SynBioBeta2024:
“Whenever there is something bold, I say it’s better to try and fail than failing to try.” - Vinod Khosla (@vkhosla) in an exciting fireside chat about the triads of longevity: ethics, elixirs and enterprises. #synbiobeta2024
Looking to make your hygiene and beauty regimen more environmentally friendly? @ProcterGamble is showcasing products with sustainable packaging and a new deodorant that’s produced using #syntheticbiology! #synbiobeta2024
We are in San Jose for SynBioBeta 2024! Find us in front of the UK Pavilion to learn how student societies can shape the future bioeconomy! #synbiobeta2024
“AI is not yet a child going to prom, it’s just a baby right now!” Charles Roberts of ARK Investment Management and Sean McClain of Absci explore the latest innovations of AI and synbio in antibody drug discovery and development at #synbiobeta2024
Exhibit hall at #synbiobeta2024 is open again! Don't forget to stop by the booths to say hello. #synbiobeta #synbio #syntheticbiology
Sean McClain of Absci and Charles Roberts of ARK Investment Management discuss the role of #AI in #syntheticbiology. They predict that leveraging AI to go after human biology will be the biggest transformation in the next 5-10 years! #synbiobeta2024 #synbiobeta #synbio #syntheticbiology
Sign up for our newsletters to stay updated on the latest news in #syntheticbiology: https://synbiobeta.com/sign-up-for-our-digest #synbiobeta2024
“We can’t be good stewards of the planet if we’re not also good stewards of capital.” - Ursheet Parikh of Mayfield speaking on the importance of both the business model and the innovation. “If you’re a founder and CEO you have to be a storyteller. Otherwise you need to go find a cofounder or CEO to tell the story.” #synbiobeta2024
What is key for navigating the investment ecosystem? Here are a few tips: Leverage partnerships so you can focus only on a few things, don't use venture dollars for CAPEX, e.g. building out facilities, make sure to play devil's advocate when developing a realistic MVP. Very insightful! #venturecapital #investing #synbio #syntheticbiology #synbiobeta #synbiobeta2024
.@Mojikarimi from @Cemvita talks about #biotech meets #climatetech. #syntheticbiology will play a massive role in natural resources where Cemvita found key drivers of change. Can we grow everything? What's our preferred future? #bioeconomy #sustainability #synbio #synbiobeta #synbiobeta2024
Sang Yup Lee from KAIST talks about using AI for predicting enzyme function. They have created neural nets where AI has developed sufficient understanding to make its own predictions without additional human labeling. #ai #enzymes #synbio #syntheticbiology #synbiobeta #synbiobeta2024
#SynBioBeta2024 Day 1:
More photos from Day 1 of #SynBioBeta2024:
Kicking off Day 2 of #synbiobeta2024 with some movement!
Ready for the run! #SynBioBeta2024
A beautiful evening in San Jose as we close the first day of #synbiobeta2024 with some mixing and refreshments!
‘Because my genome was the first to be sequenced, many papers have been published about the diseases I’m supposed to die from, including several childhood diseases.’ - Craig Venter talking to Linda Avey at #synbiobeta2024
Elaine Watson from Agfunder moderates a panel of experts on the future of cellular ag by chatting about challenges in scaling up and meeting regulatory requirements needed to commercialize globally. What's the future for cultivated meat? #synbio #syntheticbiology #synbiobeta #synbiobeta2024 #cultivatedmeat #cellularagriculture
It’s hard to believe that the flavors and fragrances like raspberry and rose in so many of our products are derived from petroleum.🛢️🤢 Today, Insempra announced $20 million in financing to advance the development of next-generation bio-based ingredients. #SynBioBeta2024
From the fireside talk with Stephen Quake, Stephen Wolfram, and Moira Gunn: In the years to come, the work of biologists will look a lot more like the work of physicists today, where universal laws give bioscientists much more deterministic answers to their queries. In an age of AI, the question remains: will there be accompanying narratives to help humans understand the answers received? #SynBioBeta2024
Maria Soloveychik from SyntheX speaks with Larry Stambaugh from Molecular Assemblies about exploring the undruggable proteome and how engineering a cell to do something it can't in vitro can really unlock moonshot achievements. #synbio #syntheticbiology #synbiobeta #synbiobeta2024
Don't forget to sign up for our newsletters! https://www.synbiobeta.com/sign-up-for-our-digest #synbiobeta2024
This team of experts are highlighting how space exploration can advance biological applications and introduce new commercialization opportunities. What can #syntheticbiology do to help produce in #space? #synbio #synbiobeta #synbiobeta2024
Can we stop aging? Come and find out at #synbiobeta2024. Join experts and industry speakers as they delve into the nuances of longevity research. #bioeconomy #biotechnology #immortality #synbiobeta #startups #longevity